Literature DB >> 25820388

9H-Carbazole Derivatives Containing the N-Benzyl-1,2,3-triazole Moiety as New Acetylcholinesterase Inhibitors.

Hamidreza Akrami1, Bibi F Mirjalili, Mehdi Khoobi, Alireza Moradi, Hamid Nadri, Saeed Emami, Alireza Foroumadi, Mohsen Vosooghi, Abbas Shafiee.   

Abstract

A series of triazole-containing carbazole derivatives were designed as new anti-acetylcholinesterase (AChE) agents. The target compounds 6a-q were simply prepared via a one-pot three-component click reaction of N-propargyl-9H-carbazole, sodium azide, and an appropriate benzyl halide. The in vitro anti-cholinesterase assay showed that the unsubstituted benzyl derivative 6p along with the 2-F, 2-Me, 3-Me, 3-MeO, and 3-F analogs (6a, 6c, and 6g-i) had significant anti-AChE activity (IC50s ≤ 3.8 μM). Among them, the 2-methylbenzyl derivative 6c with an IC50 value of 1.9 μM was the most active compound. The SAR studies revealed that small halogen atoms such as the fluorine atom or electron-donating groups such as methyl or methoxy at the ortho or meta positions of the benzyl pendent group could be tolerated or improved the anti-AChE activity.
© 2015 WILEY-VCH Verlag GmbH & Co. KGaA, Weinheim.

Entities:  

Keywords:  9H-Carbazole; Acetylcholinesterase; Alzheimer's disease; Click chemistry; Docking study; Triazole

Mesh:

Substances:

Year:  2015        PMID: 25820388     DOI: 10.1002/ardp.201400365

Source DB:  PubMed          Journal:  Arch Pharm (Weinheim)        ISSN: 0365-6233            Impact factor:   3.751


  2 in total

1.  Design, synthesis, in vivo and in vitro studies of 1,2,3,4-tetrahydro-9H-carbazole derivatives, highly selective and potent butyrylcholinesterase inhibitors.

Authors:  Roshanak Ghobadian; Roghaieh Esfandyari; Hamid Nadri; Alireza Moradi; Mohammad Mahdavi; Tahmineh Akbarzadeh; Hossein Khaleghzadeh-Ahangar; Najmeh Edraki; Mohammad Sharifzadeh; Mohsen Amini
Journal:  Mol Divers       Date:  2019-03-29       Impact factor: 2.943

2.  The Hypnotic, Anxiolytic, and Antinociceptive Profile of a Novel µ-Opioid Agonist.

Authors:  Guilherme Carneiro Montes; Bianca Nascimento Monteiro da Silva; Bismarck Rezende; Roberto Takashi Sudo; Vitor Francisco Ferreira; Fernando de Carvalho da Silva; Angelo da Cunha Pinto; Bárbara Vasconcellos da Silva; Gisele Zapata-Sudo
Journal:  Molecules       Date:  2017-05-16       Impact factor: 4.411

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.